Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Maurer

Showing results (1-10 of 243) with videos related to

Pageof 25
Sort By:
Leukemia & Lymphoma|March 23, 2013
The potential of serum light chains in diffuse large B-cell lymphomaMatthew J Maurer
Blood|September 7, 2019
POD24 in MZL: a means to an end or an end point in itself?Matthew J Maurer
Haematologica|November 2, 2023
The International Prognostic Index in aggressive B-cell lymphomaMatthew J Maurer
British Journal of Haematology|April 14, 2021
Reversing the restrictive trend in diffuse large B-cell lymphoma trial eligibility: it's time to open the gates!Arushi Khurana, Matthew J Maurer
Blood|February 28, 2025
End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?Mengyang Di, Matthew J Maurer, Christopher R Flowers
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Survival prediction based on inherited gene variation analysisMine S Cicek, Matthew J Maurer, Ellen L Goode
The Journal of Biological Chemistry|September 25, 2008
Degradation of a cytosolic protein requires endoplasmic reticulum-associated degradation machineryMeredith Boyle Metzger, Matthew J Maurer, Beverley M Dancy, et al.
American Journal of Hematology|October 17, 2022
Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphomaGrzegorz Nowakowski, Matthew J Maurer, James R Cerhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Reply to V. Pitini et al and L.J. CostaCarrie A Thompson, Herve Ghesquieres, Matthew J Maurer, et al.
Blood Cancer Journal|March 13, 2021
JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axisKang Le, Linda E Wellik, Matthew J Maurer, et al.
Pageof 25

Showing results (1-10 of 243) with videos related to

Sort By:
Pageof 25
Leukemia & Lymphoma|March 23, 2013
The potential of serum light chains in diffuse large B-cell lymphomaMatthew J Maurer
Blood|September 7, 2019
POD24 in MZL: a means to an end or an end point in itself?Matthew J Maurer
Haematologica|November 2, 2023
The International Prognostic Index in aggressive B-cell lymphomaMatthew J Maurer
British Journal of Haematology|April 14, 2021
Reversing the restrictive trend in diffuse large B-cell lymphoma trial eligibility: it's time to open the gates!Arushi Khurana, Matthew J Maurer
Blood|February 28, 2025
End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?Mengyang Di, Matthew J Maurer, Christopher R Flowers
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Survival prediction based on inherited gene variation analysisMine S Cicek, Matthew J Maurer, Ellen L Goode
The Journal of Biological Chemistry|September 25, 2008
Degradation of a cytosolic protein requires endoplasmic reticulum-associated degradation machineryMeredith Boyle Metzger, Matthew J Maurer, Beverley M Dancy, et al.
American Journal of Hematology|October 17, 2022
Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphomaGrzegorz Nowakowski, Matthew J Maurer, James R Cerhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Reply to V. Pitini et al and L.J. CostaCarrie A Thompson, Herve Ghesquieres, Matthew J Maurer, et al.
Blood Cancer Journal|March 13, 2021
JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axisKang Le, Linda E Wellik, Matthew J Maurer, et al.
Pageof 25